Three-member expert panel will oversee process to dispose of the Sinovac-CoronaVac doses that expired in December 2023.

Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s Cell Pouch Bio-hybrid Organ as a functional cure for type 1 ...

Disagreements between high- and lower-income countries have left the pandemic preparedness treaty in intensive care. The prescription? Developing nations can look to each other for health equity, ...

As the cryptocurrency market faces renewed turbulence, Bitcoin (BTC) has pulled back to around $80,000, while Ethereum (ETH) extends its slide. According to CoinGlass, market sentiment has sunk into ...

Sinovac Biotech (SVA) announced that Sinovac has received a formal court order from the Privy Council following the previously announced Privy ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases, announces the publication of ...

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court ...

O secretário de Indústria, Comércio e Serviços do Paraná, Ricardo Barros (Progressistas), esteve em sua cidade natal, Maringá ...

FILE-A technician works in a lab at Sinovac Biotech where the company is producing their potential COVID-19 vaccine CoronaVac during a media tour on September 24, 2020 in Beijing, China. (Photo by ...

A Sinovac, farmacêutica multinacional, e o Tecpar, Instituto de Tecnologia do Paraná, anunciam a assinatura de um acordo que prevê o fortalecimento da produção local de vacinas e maior ...

U.S. large pharmaceutical companies and investment firms are paying attention to Chinese biotechnology corporations. Despite a years-long investment chill in biotechnology and U.S.-China trade ...

The global meningococcal vaccine market is experiencing significant growth, driven by rising incidences of the disease worldwide. As of 2024, the market is estimated to be valued at USD 3,950.2 ...